The global Veterinary Drug market size was valued at USD 24410 million in 2022 and is forecast to a readjusted size of USD 34950 million by 2029 with a CAGR of 5.3% during review period.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
This report is a detailed and comprehensive analysis for global Veterinary Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veterinary Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Veterinary Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Veterinary Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Veterinary Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Pets
Cattle
Poultry
Swine
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Increasing pet ownership and livestock farming globally drive higher demand for veterinary drugs.
- Advancements in animal health technology and R&D are leading to more effective, specialized drugs.
Weaknesses:
- Regulatory hurdles and high approval costs may slow down drug development and market entry.
- Limited access to veterinary healthcare in developing regions may restrict market growth.
Opportunities:
- Expansion of animal health markets in emerging economies presents significant growth potential.
- Rising awareness of animal welfare and preventive care opens up new avenues for drug sales.
Threats:
- Stringent regulatory frameworks and evolving animal health policies could increase market complexity.
- The emergence of antimicrobial resistance could limit the effectiveness of existing veterinary drugs.
Political:
- Increasing government regulations and policies on animal health can impact the approval process for veterinary drugs.
- Trade agreements and animal health regulations in different regions may affect the distribution and availability of veterinary drugs.
Economic:
- Growing disposable income in emerging markets is leading to higher expenditure on pet healthcare.
- Economic instability in key markets may impact spending on non-essential veterinary products.
Social:
- Rising awareness about animal welfare and preventive healthcare boosts the demand for veterinary drugs.
- The aging pet population in many developed countries creates a greater need for chronic disease management.
Technological:
- Advancements in biotechnology and diagnostics lead to the development of innovative veterinary drugs.
- Increased adoption of digital health tools for animals offers new opportunities for drug development and monitoring.
Environmental:
- Growing concerns about the environmental impact of pharmaceutical waste influence the development of eco-friendly drug formulations.
- Climate change and its impact on animal health may lead to new challenges for veterinary drugs, such as the need for treatments for emerging diseases.
Legal:
- Strict regulations surrounding animal drug approvals and safety standards influence market dynamics.
- Intellectual property rights and patent laws play a critical role in protecting new veterinary drug innovations.
Suppliers:
- Pharmaceutical companies, biotechnology firms, and research institutions provide the raw materials and innovations needed for veterinary drugs.
- Regulatory bodies and government agencies influence the production standards and approval processes for veterinary drugs.
Inputs:
- Active pharmaceutical ingredients (APIs), research data, and technology are essential for developing veterinary drugs.
- Market research, clinical trials, and regulatory approvals are key inputs to ensure drug efficacy and safety.
Process:
- Drug development involves R&D, testing, and regulatory approval before reaching the market.
- Manufacturing processes ensure consistent production of high-quality veterinary drugs, meeting safety standards.
Outputs:
- Approved and manufactured veterinary drugs, including vaccines, antibiotics, and parasiticides, are made available for animals.
- Market-ready products that address both preventative care and treatment of animal diseases.
Customers:
- Veterinarians and clinics require veterinary drugs to treat animals and promote overall health.
- Pet owners, livestock farmers, and agricultural businesses are the primary consumers of veterinary drugs.
Threat of New Entrants:
- High R&D costs and stringent regulatory requirements create barriers for new companies entering the market.
- Established brands and market leaders have significant control over distribution channels and customer loyalty, making entry difficult.
Bargaining Power of Suppliers:
- A limited number of suppliers for key active pharmaceutical ingredients (APIs) increases their bargaining power.
- Companies reliant on specific raw materials or advanced technology may face challenges in negotiating costs with suppliers.
Bargaining Power of Buyers:
- Veterinarians and large-scale animal health buyers (e.g., farms) have strong bargaining power due to bulk purchasing and price sensitivity.
- Increased consumer awareness of animal health may drive demand for higher-quality drugs, affecting buyer power.
Threat of Substitutes:
- Natural or alternative treatments for animal diseases present a growing threat to conventional veterinary drugs.
- The availability of generic veterinary drugs creates price competition and offers substitutes to branded products.
Industry Rivalry:
- Intense competition among established pharmaceutical companies and new entrants drives innovation but also leads to price pressures.
- Differentiation based on drug effectiveness, brand reputation, and customer relationships intensifies rivalry in the market.
Raw Materials and Ingredients:
- Active pharmaceutical ingredients (APIs) and excipients are sourced from specialized suppliers, with some relying on global supply chains, potentially facing disruptions.
- The availability and cost of raw materials, including synthetic and biologic components, directly affect the cost structure of veterinary drugs.
Research and Development:
- Ongoing investment in R&D by pharmaceutical companies is essential for developing innovative treatments and vaccines for emerging diseases in animals.
- Regulatory approval processes for new drugs require extensive clinical trials and testing, influencing the pace of development and market entry.
Technology and Manufacturing:
- Advanced technologies, such as biotechnology and gene editing, are shaping the future of veterinary drug manufacturing, improving drug efficacy and safety.
- Manufacturing capabilities, including compliance with GMP (Good Manufacturing Practices), are critical in ensuring consistent production of high-quality veterinary drugs.
Regulatory Environment:
- Stringent regulatory frameworks and government agencies, like the FDA and EMA, regulate the approval process, ensuring drugs meet safety and efficacy standards.
- Changes in regulations, such as new policies on antimicrobial resistance, can affect the formulation and distribution of certain veterinary drugs.
Manufacturing and Production:
- The production of veterinary drugs requires compliance with stringent manufacturing standards, including Good Manufacturing Practices (GMP), to ensure quality control.
- Innovations in manufacturing processes, such as automated systems and biotechnology advancements, are increasing efficiency and reducing production costs.
Distribution and Supply Chain:
- Global distribution networks, including wholesalers and specialized veterinary drug distributors, are key to ensuring timely delivery of veterinary drugs.
- Supply chain complexities, including regulatory requirements and logistical challenges, affect the availability and pricing of veterinary drugs across regions.
End Users and Customers:
- Veterinarians, pet owners, and livestock farmers are the primary consumers of veterinary drugs, with increasing demand driven by pet care and livestock health management.
- Large-scale agricultural businesses and animal health institutions play a significant role in driving bulk purchases of veterinary drugs.
Market Trends and Demand:
- Rising awareness of animal welfare and preventive healthcare is driving greater demand for vaccines, antibiotics, and specialized treatments.
- The growing trend of pet humanization, particularly in developed markets, is contributing to an increase in spending on high-quality veterinary products.
Chapter 1, to describe Veterinary Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Drug, with price, sales, revenue and global market share of Veterinary Drug from 2018 to 2023.
Chapter 3, the Veterinary Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Drug.
Chapter 14 and 15, to describe Veterinary Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Veterinary Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Veterinary Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Anti-Infectives
1.3.3 Anti-Inflammatory
1.3.4 Parasiticides
1.3.5 Analgesics
1.3.6 Sedatives
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Veterinary Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pets
1.4.3 Cattle
1.4.4 Poultry
1.4.5 Swine
1.4.6 Others
1.5 Global Veterinary Drug Market Size & Forecast
1.5.1 Global Veterinary Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Veterinary Drug Sales Quantity (2018-2029)
1.5.3 Global Veterinary Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Veterinary Drug Product and Services
2.1.4 Zoetis Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Elanco
2.2.1 Elanco Details
2.2.2 Elanco Major Business
2.2.3 Elanco Veterinary Drug Product and Services
2.2.4 Elanco Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Elanco Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Veterinary Drug Product and Services
2.3.4 Boehringer Ingelheim Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Veterinary Drug Product and Services
2.4.4 Merck Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments/Updates
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Veterinary Drug Product and Services
2.5.4 Virbac Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Virbac Recent Developments/Updates
2.6 Ceva
2.6.1 Ceva Details
2.6.2 Ceva Major Business
2.6.3 Ceva Veterinary Drug Product and Services
2.6.4 Ceva Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ceva Recent Developments/Updates
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Veterinary Drug Product and Services
2.7.4 Vetoquinol Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Vetoquinol Recent Developments/Updates
2.8 Dechra
2.8.1 Dechra Details
2.8.2 Dechra Major Business
2.8.3 Dechra Veterinary Drug Product and Services
2.8.4 Dechra Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dechra Recent Developments/Updates
2.9 Norbrook
2.9.1 Norbrook Details
2.9.2 Norbrook Major Business
2.9.3 Norbrook Veterinary Drug Product and Services
2.9.4 Norbrook Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Norbrook Recent Developments/Updates
2.10 Phibro
2.10.1 Phibro Details
2.10.2 Phibro Major Business
2.10.3 Phibro Veterinary Drug Product and Services
2.10.4 Phibro Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Phibro Recent Developments/Updates
2.11 Huvepharma
2.11.1 Huvepharma Details
2.11.2 Huvepharma Major Business
2.11.3 Huvepharma Veterinary Drug Product and Services
2.11.4 Huvepharma Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Huvepharma Recent Developments/Updates
2.12 Hipra
2.12.1 Hipra Details
2.12.2 Hipra Major Business
2.12.3 Hipra Veterinary Drug Product and Services
2.12.4 Hipra Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hipra Recent Developments/Updates
2.13 Ouro Fino Saude
2.13.1 Ouro Fino Saude Details
2.13.2 Ouro Fino Saude Major Business
2.13.3 Ouro Fino Saude Veterinary Drug Product and Services
2.13.4 Ouro Fino Saude Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ouro Fino Saude Recent Developments/Updates
2.14 CAHIC
2.14.1 CAHIC Details
2.14.2 CAHIC Major Business
2.14.3 CAHIC Veterinary Drug Product and Services
2.14.4 CAHIC Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CAHIC Recent Developments/Updates
2.15 Orion
2.15.1 Orion Details
2.15.2 Orion Major Business
2.15.3 Orion Veterinary Drug Product and Services
2.15.4 Orion Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Orion Recent Developments/Updates
2.16 Ringpu Biology
2.16.1 Ringpu Biology Details
2.16.2 Ringpu Biology Major Business
2.16.3 Ringpu Biology Veterinary Drug Product and Services
2.16.4 Ringpu Biology Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ringpu Biology Recent Developments/Updates
2.17 Nippon Zenyaku Kogyo
2.17.1 Nippon Zenyaku Kogyo Details
2.17.2 Nippon Zenyaku Kogyo Major Business
2.17.3 Nippon Zenyaku Kogyo Veterinary Drug Product and Services
2.17.4 Nippon Zenyaku Kogyo Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates
2.18 Farmavet-Pasteur
2.18.1 Farmavet-Pasteur Details
2.18.2 Farmavet-Pasteur Major Business
2.18.3 Farmavet-Pasteur Veterinary Drug Product and Services
2.18.4 Farmavet-Pasteur Veterinary Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Farmavet-Pasteur Recent Developments/Updates
3 Competitive Environment: Veterinary Drug by Manufacturer
3.1 Global Veterinary Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Veterinary Drug Revenue by Manufacturer (2018-2023)
3.3 Global Veterinary Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Veterinary Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Veterinary Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Veterinary Drug Manufacturer Market Share in 2022
3.5 Veterinary Drug Market: Overall Company Footprint Analysis
3.5.1 Veterinary Drug Market: Region Footprint
3.5.2 Veterinary Drug Market: Company Product Type Footprint
3.5.3 Veterinary Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Veterinary Drug Market Size by Region
4.1.1 Global Veterinary Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Veterinary Drug Consumption Value by Region (2018-2029)
4.1.3 Global Veterinary Drug Average Price by Region (2018-2029)
4.2 North America Veterinary Drug Consumption Value (2018-2029)
4.3 Europe Veterinary Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Veterinary Drug Consumption Value (2018-2029)
4.5 South America Veterinary Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Veterinary Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Veterinary Drug Sales Quantity by Type (2018-2029)
5.2 Global Veterinary Drug Consumption Value by Type (2018-2029)
5.3 Global Veterinary Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Veterinary Drug Sales Quantity by Application (2018-2029)
6.2 Global Veterinary Drug Consumption Value by Application (2018-2029)
6.3 Global Veterinary Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Veterinary Drug Sales Quantity by Type (2018-2029)
7.2 North America Veterinary Drug Sales Quantity by Application (2018-2029)
7.3 North America Veterinary Drug Market Size by Country
7.3.1 North America Veterinary Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Veterinary Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Veterinary Drug Sales Quantity by Type (2018-2029)
8.2 Europe Veterinary Drug Sales Quantity by Application (2018-2029)
8.3 Europe Veterinary Drug Market Size by Country
8.3.1 Europe Veterinary Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Veterinary Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Veterinary Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Veterinary Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Veterinary Drug Market Size by Region
9.3.1 Asia-Pacific Veterinary Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Veterinary Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Veterinary Drug Sales Quantity by Type (2018-2029)
10.2 South America Veterinary Drug Sales Quantity by Application (2018-2029)
10.3 South America Veterinary Drug Market Size by Country
10.3.1 South America Veterinary Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Veterinary Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Veterinary Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Veterinary Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Veterinary Drug Market Size by Country
11.3.1 Middle East & Africa Veterinary Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Veterinary Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Veterinary Drug Market Drivers
12.2 Veterinary Drug Market Restraints
12.3 Veterinary Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Veterinary Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Drug
13.3 Veterinary Drug Production Process
13.4 Veterinary Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Veterinary Drug Typical Distributors
14.3 Veterinary Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Veterinary Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Veterinary Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Veterinary Drug Product and Services
Table 6. Zoetis Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Elanco Basic Information, Manufacturing Base and Competitors
Table 9. Elanco Major Business
Table 10. Elanco Veterinary Drug Product and Services
Table 11. Elanco Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Elanco Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Veterinary Drug Product and Services
Table 16. Boehringer Ingelheim Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Veterinary Drug Product and Services
Table 21. Merck Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Recent Developments/Updates
Table 23. Virbac Basic Information, Manufacturing Base and Competitors
Table 24. Virbac Major Business
Table 25. Virbac Veterinary Drug Product and Services
Table 26. Virbac Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Virbac Recent Developments/Updates
Table 28. Ceva Basic Information, Manufacturing Base and Competitors
Table 29. Ceva Major Business
Table 30. Ceva Veterinary Drug Product and Services
Table 31. Ceva Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ceva Recent Developments/Updates
Table 33. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 34. Vetoquinol Major Business
Table 35. Vetoquinol Veterinary Drug Product and Services
Table 36. Vetoquinol Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Vetoquinol Recent Developments/Updates
Table 38. Dechra Basic Information, Manufacturing Base and Competitors
Table 39. Dechra Major Business
Table 40. Dechra Veterinary Drug Product and Services
Table 41. Dechra Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Dechra Recent Developments/Updates
Table 43. Norbrook Basic Information, Manufacturing Base and Competitors
Table 44. Norbrook Major Business
Table 45. Norbrook Veterinary Drug Product and Services
Table 46. Norbrook Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Norbrook Recent Developments/Updates
Table 48. Phibro Basic Information, Manufacturing Base and Competitors
Table 49. Phibro Major Business
Table 50. Phibro Veterinary Drug Product and Services
Table 51. Phibro Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Phibro Recent Developments/Updates
Table 53. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 54. Huvepharma Major Business
Table 55. Huvepharma Veterinary Drug Product and Services
Table 56. Huvepharma Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Huvepharma Recent Developments/Updates
Table 58. Hipra Basic Information, Manufacturing Base and Competitors
Table 59. Hipra Major Business
Table 60. Hipra Veterinary Drug Product and Services
Table 61. Hipra Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hipra Recent Developments/Updates
Table 63. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 64. Ouro Fino Saude Major Business
Table 65. Ouro Fino Saude Veterinary Drug Product and Services
Table 66. Ouro Fino Saude Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ouro Fino Saude Recent Developments/Updates
Table 68. CAHIC Basic Information, Manufacturing Base and Competitors
Table 69. CAHIC Major Business
Table 70. CAHIC Veterinary Drug Product and Services
Table 71. CAHIC Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. CAHIC Recent Developments/Updates
Table 73. Orion Basic Information, Manufacturing Base and Competitors
Table 74. Orion Major Business
Table 75. Orion Veterinary Drug Product and Services
Table 76. Orion Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Orion Recent Developments/Updates
Table 78. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 79. Ringpu Biology Major Business
Table 80. Ringpu Biology Veterinary Drug Product and Services
Table 81. Ringpu Biology Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ringpu Biology Recent Developments/Updates
Table 83. Nippon Zenyaku Kogyo Basic Information, Manufacturing Base and Competitors
Table 84. Nippon Zenyaku Kogyo Major Business
Table 85. Nippon Zenyaku Kogyo Veterinary Drug Product and Services
Table 86. Nippon Zenyaku Kogyo Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Nippon Zenyaku Kogyo Recent Developments/Updates
Table 88. Farmavet-Pasteur Basic Information, Manufacturing Base and Competitors
Table 89. Farmavet-Pasteur Major Business
Table 90. Farmavet-Pasteur Veterinary Drug Product and Services
Table 91. Farmavet-Pasteur Veterinary Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Farmavet-Pasteur Recent Developments/Updates
Table 93. Global Veterinary Drug Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 94. Global Veterinary Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Veterinary Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 96. Market Position of Manufacturers in Veterinary Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Veterinary Drug Production Site of Key Manufacturer
Table 98. Veterinary Drug Market: Company Product Type Footprint
Table 99. Veterinary Drug Market: Company Product Application Footprint
Table 100. Veterinary Drug New Market Entrants and Barriers to Market Entry
Table 101. Veterinary Drug Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Veterinary Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 103. Global Veterinary Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 104. Global Veterinary Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Veterinary Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Veterinary Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 107. Global Veterinary Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 108. Global Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 109. Global Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 110. Global Veterinary Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Veterinary Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Veterinary Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 113. Global Veterinary Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 114. Global Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 115. Global Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 116. Global Veterinary Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Veterinary Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Veterinary Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Veterinary Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 120. North America Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 121. North America Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 122. North America Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 123. North America Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 124. North America Veterinary Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 125. North America Veterinary Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 126. North America Veterinary Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Veterinary Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 129. Europe Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 130. Europe Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 131. Europe Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 132. Europe Veterinary Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 133. Europe Veterinary Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 134. Europe Veterinary Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Veterinary Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 137. Asia-Pacific Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 138. Asia-Pacific Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 139. Asia-Pacific Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 140. Asia-Pacific Veterinary Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 141. Asia-Pacific Veterinary Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 142. Asia-Pacific Veterinary Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Veterinary Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 145. South America Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 146. South America Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 147. South America Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 148. South America Veterinary Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 149. South America Veterinary Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 150. South America Veterinary Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Veterinary Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Veterinary Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 153. Middle East & Africa Veterinary Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 154. Middle East & Africa Veterinary Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 155. Middle East & Africa Veterinary Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 156. Middle East & Africa Veterinary Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 157. Middle East & Africa Veterinary Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 158. Middle East & Africa Veterinary Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Veterinary Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Veterinary Drug Raw Material
Table 161. Key Manufacturers of Veterinary Drug Raw Materials
Table 162. Veterinary Drug Typical Distributors
Table 163. Veterinary Drug Typical Customers
List of Figures
Figure 1. Veterinary Drug Picture
Figure 2. Global Veterinary Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Veterinary Drug Consumption Value Market Share by Type in 2022
Figure 4. Anti-Infectives Examples
Figure 5. Anti-Inflammatory Examples
Figure 6. Parasiticides Examples
Figure 7. Analgesics Examples
Figure 8. Sedatives Examples
Figure 9. Others Examples
Figure 10. Global Veterinary Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Veterinary Drug Consumption Value Market Share by Application in 2022
Figure 12. Pets Examples
Figure 13. Cattle Examples
Figure 14. Poultry Examples
Figure 15. Swine Examples
Figure 16. Others Examples
Figure 17. Global Veterinary Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Veterinary Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Veterinary Drug Sales Quantity (2018-2029) & (M Units)
Figure 20. Global Veterinary Drug Average Price (2018-2029) & (USD/Unit)
Figure 21. Global Veterinary Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Veterinary Drug Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Veterinary Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Veterinary Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Veterinary Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Veterinary Drug Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Veterinary Drug Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Veterinary Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Veterinary Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Veterinary Drug Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Veterinary Drug Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Veterinary Drug Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Veterinary Drug Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Veterinary Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 36. Global Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Veterinary Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Veterinary Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 39. North America Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Veterinary Drug Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Veterinary Drug Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Veterinary Drug Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Veterinary Drug Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Veterinary Drug Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Veterinary Drug Consumption Value Market Share by Region (2018-2029)
Figure 59. China Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Veterinary Drug Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Veterinary Drug Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Veterinary Drug Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Veterinary Drug Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Veterinary Drug Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Veterinary Drug Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Veterinary Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Veterinary Drug Market Drivers
Figure 80. Veterinary Drug Market Restraints
Figure 81. Veterinary Drug Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Veterinary Drug in 2022
Figure 84. Manufacturing Process Analysis of Veterinary Drug
Figure 85. Veterinary Drug Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
